2022
DATE
03 - 17
Vazyme and IFC Launch Cooperation on International Expansion
Biotechnology company Vazyme and the International Finance Corporation (IFC), a member of the World Bank Group, have agreed to cooperate on overseas expansion opportunities in some countries of three rigions, APAC, EU and Larin America,. Vazyme is exploring the possibility of constructing medical-di
Read More
2022
DATE
03 - 08
#BreakTheBias — Girls Can Do Whatever They Want To Do
The theme for International Women’s Day, 8 March, 2022 (IWD 2022) is, “Gender equality today for a sustainable tomorrow”. Advancing gender equality is also what we have been doing since the founding of company. At Vazyme, women and girls are effective and powerful leaders and change-makers for corporate management and operation. They are involved in many vital jobs here, from key R&D departments, production workshops to functional units. Their participation and leadership results in many important moments of company history.
Read More
2021
DATE
11 - 15
Vazyme goes public on Shanghai Stock Exchange today
On November 15, 2021, Nanjing Vazyme Biotech Co.,;Ltd.(Vazyme)went public on the STAR MARKET of the Shanghai Stock Exchange under the stock code 688105. Founded in Nanjing in 2012, Vazyme develops technologies and products related to functional proteins including enzymes, antigens and antibodies as
Read More
Committed to providing products and services with excellent performance for the field of bio medicine and life science research

OUR PRODUCTS

MORE LINKS

CONTACT US

Address: Building D2, Hongfeng science and
Technology Park, Kechuang Road, Nanjing
Economic and Technological Development
Zone, Jiangsu Province, China
Tel:+86 400-969-0586
Copyright @ 2021 Nanjing Vazyme Biotech Co.,Ltd. All Rights Reserved